Today: 9 November 2025
Subscribe

Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Moderna’s Wild Ride: Vaccine Hopes Fuel Stock Pop Amid “One-Hit Wonder” Fears

Moderna’s Wild Ride: Vaccine Hopes Fuel Stock Pop Amid “One-Hit Wonder” Fears

Stock Rebounds on Moderna’s “Make-or-Break” Week Moderna’s stock is back in the spotlight after a turbulent week of news that sent the Nasdaq-listed shares swinging. On Wednesday, MRNA jumped over 5%, climbing to around $27.7 by market close marketbeat.com. The mini-rally came amid a flurry of developments – from upbeat trial data on a new cancer vaccine to analysts debating whether Moderna’s future is bright or bleak. Even after the pop, however, Moderna’s stock is a shadow of its former self: shares have cratered roughly 80% below last year’s levels marketbeat.com and are down one-third in 2025 alone. The once
16 October 2025
 ·  ·  ·  ·  · 
Kelly Services’ Tech-Driven Hiring Triumphs Spark Stock Rally Hopes

Kelly Services’ Tech-Driven Hiring Triumphs Spark Stock Rally Hopes

Double Honors in Staffing Leadership Kelly Services has grabbed headlines by earning dual top honors from leading industry analyst Everest Group. In the newly released 2025 U.S. Contingent Staffing PEAK Matrix assessments, Kelly was designated both a Leader and a Star Performer, recognizing its superior capabilities and momentum in supplying talent. Notably, Kelly achieved this in both the professional/administrative and industrial staffing categories, marking “the first time any firm” has ever swept both distinctions across all evaluated segments ts2.tech. This unprecedented feat underscores how far the 77-year-old staffing giant has evolved beyond traditional temp services into a tech-savvy talent solutions
16 October 2025
 ·  ·  ·  ·  · 
Theriva Biologics Stock Skyrockets 92% on Cancer Trial Breakthrough – What’s Next for TOVX?

Theriva Biologics Stock Skyrockets 92% on Cancer Trial Breakthrough – What’s Next for TOVX?

Recent Clinical Developments and Pipeline Updates Theriva Biologics – a Rockville, MD-based clinical-stage biotech – has made headlines with promising cancer trial results. On October 13, 2025, the company announced that expanded data from its VIRAGE Phase 2b trial in metastatic pancreatic ductal adenocarcinoma will be presented at the ESMO 2025 Congress on Oct. 20 ts2.tech. In this trial, patients receiving VCN-01 (an oncolytic adenovirus therapy) plus standard gemcitabine/nab-paclitaxel chemo showed markedly better outcomes than chemo alone. Interim data filed with the SEC reveal VCN-01 improved median overall survival to around 11–14 months versus ~8–11 months for chemo-only patients ts2.tech.
16 October 2025
 ·  ·  ·  · 
LOBO EV Tech Rebrands & Sparks Trading Frenzy – What Investors Need to Know

LOBO EV Tech Rebrands & Sparks Trading Frenzy – What Investors Need to Know

Nasdaq Debut and Volatile Trading Lobo’s corporate makeover took effect on Oct. 16, when shareholders’ approval of a name change (dropping the “EV”) and a share reclassification became official tipranks.com. That morning, LOBO opened on Nasdaq at $0.86 and oscillated up to $0.97 before closing flat around $0.93 reuters.com. This frenetic trading came on unusually heavy volume, underscoring heightened interest around the rebrand. The Class A ordinary shares carry the same ticker “LOBO” but signal a new chapter for the company’s capital structure. Management framed the changes as a strategy to “enhance [LOBO’s] market presence” and reflect broader tech ambitions beyond just
16 October 2025
 ·  ·  ·  ·  · 
Marsh & McLennan’s Q3 Profit Jumps 11% Amid Rebrand to “Marsh” – What’s Next for MMC Stock?

Marsh & McLennan’s Q3 Profit Jumps 11% Amid Rebrand to “Marsh” – What’s Next for MMC Stock?

Q3 2025 Earnings: Solid Growth and an 11% Profit Jump Marsh & McLennan delivered a strong third quarter, topping expectations on both the top and bottom lines. Revenue reached $6.4 billion, up 11% from a year ago (4% on an underlying, constant-currency basis) stocktitan.net stocktitan.net. This was driven by double-digit growth in its core insurance broking unit and steady gains in consulting. The Risk & Insurance Services division (which includes its Marsh insurance brokerage and Guy Carpenter reinsurance arm) saw revenue surge +13% year-over-year to $3.9 billion stocktitan.net, boosted by firm insurance pricing earlier in the year and a rebound in client
16 October 2025
 ·  ·  ·  ·  · 
Axon Stock Plunges 8% Amid Market Rally – Analysts See Big Upside Ahead

Axon Stock Plunges 8% Amid Market Rally – Analysts See Big Upside Ahead

Axon Stock Sinks Despite Market Strength Axon shares suffered an unexpected jolt mid-week, falling over 8% in a single session – a steep one-day drop for a typically steady climber. The slide to $644.99 nasdaq.com on Wednesday came with no obvious bad news from the company. In fact, broader market conditions were positive: U.S. stocks rose on the same day on optimism about trade and interest rates ts2.tech. This made Axon’s decline stand out even more, as the stock vastly underperformed major indexes. Technical factors likely played a role. Axon’s plunge pushed it below its 200-day moving average (~$677) nasdaq.com,
16 October 2025
 ·  ·  ·  ·  · 
NuScale Stock Skyrockets on Historic SMR Deal – Can GE Vernova Catch Up in the Nuclear Boom?

NuScale Stock Skyrockets on Historic SMR Deal – Can GE Vernova Catch Up in the Nuclear Boom?

NuScale’s Historic SMR Deal Sparks a Nuclear Stock Rally NuScale Power’s stock is on fire after the company secured a massive 6 gigawatt SMR deployment program with the Tennessee Valley Authority (TVA) – “the largest SMR deployment in U.S. history,” according to NuScale ts2.tech. The deal, executed via NuScale’s ENTRA1 Energy venture, will see up to six 77 MWe modular reactors installed in TVA’s service area, enough to power ~4.5 million homes and dozens of data centers ts2.tech. Investors cheered the news: on October 13, SMR shares spiked ~14% intraday, and by mid-week the stock was trading around $55 – roughly 20% higher
16 October 2025
 ·  ·  ·  ·  ·  · 
Duke Energy Stock Soars to Record High Amid Grid Modernization Boom – What’s Next?

Duke Energy Stock Soars to Record High Amid Grid Modernization Boom – What’s Next?

Record High on Robust Performance Duke Energy’s share price has been on a steady upswing, recently reaching a record high of $127.85 ph.investing.com. As of October 16, the stock hovers in the upper-$120s after a strong multi-week rally. It closed at $127.02 on Oct. 10 – then its highest level of 2025 ts2.tech – and pushed even higher in the following days. Year-to-date, Duke has returned roughly 15–20% ph.investing.com ts2.tech, dramatically outperforming the broader utilities sector. Over the past five years, Duke delivered about a 62% total return ts2.tech, handily beating many peer utilities and underscoring the company’s steady growth
16 October 2025
 ·  ·  ·  ·  · 
U.S. Bancorp Stock Soars on Earnings Beat, Dividend Hike, and New Crypto Push

U.S. Bancorp Stock Soars on Earnings Beat, Dividend Hike, and New Crypto Push

USB Stock Price & Recent Trends U.S. Bancorp’s stock (USB) is trading around $47 per share following the earnings news, up from roughly $46 before the report. The upbeat Q3 results sparked a ~3% jump in pre-market and early session trading chartmill.com, as investors reacted to the better-than-expected profit numbers. This marks a sharp reversal of the stock’s recent trajectory – over the past month USB had slid about 6% amid market-wide volatility and rising interest rates chartmill.com. Despite today’s pop, U.S. Bancorp shares remain roughly flat year-to-date, underperforming some rival banks. For instance, Wells Fargo’s stock has surged ~27%
16 October 2025
 ·  ·  ·  ·  · 
Micron (MU) Stock Hits Record Highs on AI Frenzy – Analysts See More Upside Ahead

Micron (MU) Stock Hits Record Highs on AI Frenzy – Analysts See More Upside Ahead

Stock Performance: AI Hype Sends Micron Soaring Micron’s share price momentum in 2025 has been extraordinary. As of October, the stock has more than doubled from January levels, vastly outperforming the S&P 500 and even many tech peers ts2.tech. The rally accelerated in late September and early October when Micron hit fresh record highs, peaking intraday above $196 and closing near $192 ts2.tech. This surge reflects both company-specific optimism and broader “AI mania” lifting the semiconductor sector ts2.tech. Investors have piled into AI-related stocks, and Micron – as a key supplier of memory for AI systems – has been a
16 October 2025
 ·  ·  ·  ·  · 
Fossil Group (FOSL) Stock’s Wild 2025 Ride: Skyrockets on Turnaround Hopes, Stumbles on Debt Fears

Fossil Group (FOSL) Stock’s Wild 2025 Ride: Skyrockets on Turnaround Hopes, Stumbles on Debt Fears

Fossil Stock’s Rollercoaster 2025 Performance Fossil Group’s stock has been on a wild ride in 2025, with dramatic swings that grabbed Wall Street’s attention. After years of decline, FOSL shares staged a comeback this year – up over 60% year-to-date, vastly outperforming the broader apparel/accessories sector nasdaq.com. The rally hit a fever pitch in mid-October: on October 15, Fossil’s stock skyrocketed 41.5% in a single day, hitting $3.89 intraday (a multi-year high) and closing at $3.75 stockinvest.us. This surge was seemingly out of nowhere, and traders scrambled to pinpoint the cause. As it turned out, a confluence of positive news
16 October 2025
 ·  ·  ·  ·  · 
BNY Mellon Stock Soars on Record Earnings – Will BK’s Rally Continue?

BNY Mellon Stock Soars on Record Earnings – Will BK’s Rally Continue?

BK Stock Price & Recent Performance BNY Mellon’s stock has been on a tear in 2025. Shares are hovering around $109 as of mid-October, after rallying about +40% over the past 12 months investing.com. Year-to-date, BK is up roughly +42%, vastly outperforming the S&P 500 and many peer banks. (For perspective, Wells Fargo is +27% YTD ts2.tech.) The stock notched a 52-week high of ~$110.87 recently finviz.com and sits near that peak. Over just the last week and month, BK gained ~2–3%, reflecting a steady uptrend finviz.com. This strength has come amid a broader financial sector rebound. U.S. bank stocks
16 October 2025
 ·  ·  ·  ·  · 
1 … 66 67 68 69 70 … 171
Go toTop